Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

4.590 +0.700 (+17.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 98,938,649
Open 4.460
Bid (Size) 4.600 (10)
Ask (Size) 4.610 (83)
Prev. Close 3.890
Today's Range 4.450 - 5.150
52wk Range 1.680 - 5.150
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Geron Stock a Buy Following Its First New Drug Approval?
Find out if the high-flying biotech stock can keep on climbing higher. 
Via The Motley Fool
Crude Oil Edges Lower; Asensus Surgical Shares Jump
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
+114.49%
+114.49%
1 Month
+20.47%
+20.47%
3 Month
+104.00%
+104.00%
6 Month
+121.74%
+121.74%
1 Year
+24.39%
+24.39%

More News

Read More
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Navigating 10 Analyst Ratings For Geron
Via Benzinga
Geron Corporation: FDA Approval Fuels Stock Price Surge
Via MarketBeat
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Falls Sharply; Geron Shares Spike Higher
Via Benzinga
FDA Reverses Juul Ban. What Comes Next?
Via InvestorPlace
Exposures Product Safety
Why Is Geron (GERN) Stock Up 18% Today?
Via InvestorPlace
Exposures Product Safety
Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday
Via Benzinga
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
From Geron Corporation
Via Business Wire
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Geron (GERN) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
GERN Stock Earnings: Geron Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
From Geron Corporation
Via Business Wire
The Top 3 Penny Stocks to Buy in April 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
Via Benzinga
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
From Geron Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.